Search Results - "Archimbaud, A"

A new method for small sample space components screening: Challenges, algorithms and a case-study with Microchip by Archimbaud, A., Bergeret, F., D'Alberto, S., Bonnin, C., Soual, C.

“…Screening electronic components in space industry is a difficult challenge because there are many tests, and the sample sizes are small. In statistics, this…”
Get full text

Melanocortin 1 receptor (MC1R) gene variants may increase the risk of melanoma in France independently of clinical risk factors and UV exposure by Matichard, E, Verpillat, P, Meziani, R, Gérard, B, Descamps, V, Legroux, E, Burnouf, M, Bertrand, G, Bouscarat, F, Archimbaud, A, Picard, C, Ollivaud, L, Basset-Seguin, N, Kerob, D, Lanternier, G, Lebbe, C, Crickx, B, Grandchamp, B, Soufir, N

“…[...]at present it is not clear whether the MM risk attributed to MC1R variants is distinct from its effects on pigmentation characteristics. 8 Thirdly, the…”
Get full text

Germline mutations of the INK4a-ARF gene in patients with suspected genetic predisposition to melanoma by SOUFIR, N, LACAPERE, J. J, BOUSCARAT, F, BACCARD, M, LANTERNIER, G, SAÏAG, P, LEBBE, C, BASSET-SEGUIN, N, CRICKX, B, CAVE, H, GRANDCHAMP, B, BERTRAND, G, MATICHARD, E, MEZIANI, R, MIREBEAU, D, DESCAMPS, V, GERARD, B, ARCHIMBAUD, A, OLLIVAUD, L

“…Germline anomalies of the INK4a-ARF and Cdk4 genes were sought in a series of 89 patients suspected of having a genetic predisposition to melanoma. Patients…”
Get full text

Association study of the g.8818A > G polymorphism of the human agouti gene with melanoma risk and pigmentary characteristics in a French population by Meziani, R., Descamps, V., Gérard, B., Matichard, E., Bertrand, G., Archimbaud, A., Ollivaud, L., Saiag, P., Lebbé, C., Basset-Seguin, N., Alberti, C., Crickx, B., Grandchamp, B., Soufir, N.

Get full text

Hypersensibilité à la dacarbazine chez les malades traités pour mélanome métastatique by Levy, A., Guitera, P., Kerob, D., Ollivaud, L., Archimbaud, A., Dubertret, L., Basset-Seguin, N.

“…La dacarbazine (DTIC), chimiothérapie de référence dans le mélanome métastatique sans localisation cérébrale, est habituellement bien tolérée. L’effet…”
Get full text

Allele variations in the OCA2 gene (pink-eyed-dilution locus) are associated with genetic susceptibility to melanoma by JANNOT, Anne-Sophie, MEZIANI, Roubila, LANTERNIER, Guy, LEBBE, Celeste, SAIAG, P, CRICKX, Beatrice, CLERGET-DARPOUX, Francoise, GRANDCHAMP, Bernard, SOUFIR, Nadem, BERTRAND, Guylene, GERARD, Benedicte, DESCAMPS, Vincent, ARCHIMBAUD, Alain, PICARD, Catherine, OLLIVAUD, Laurence, BASSET-SEGUIN, Nicole, KEROB, Delphine

“…The occuloalbinism 2 (OCA2) gene, localized at 15q11, encodes a melanosomal transmembrane protein that is involved in the most common form of human…”
Get full text

L’algorithme MELAPRED apparaît comme un outil clef du dépistage ciblé du mélanome by Soufir, N., Benfodda, M., Descamps, V., Gazal, S., Madjlessi-Ezra, N., Colomb, M., Baccard, M., Archimbaud, A., Renard, F., Fite, C., Grange, A., Levy-Sitbon, C., Vuong, V., Jehou, J., Arnoult-Coudoux, E., Bachoud, A., Massart-Manil, S., Nicaise-Bergere, C., Machuel, B., Schernberg, C., Lami, M.-C., Basset-Seguin, N., Lebbe, C., Dupin, N., Wolkenstein, P., Bagot, M., Saiag, P., Fraitag, S., Bensussan, A., Marinho, E., Nagore, E., Kumar, R., Grange, F.

“…Le mélanome a un pronostic redoutable en cas de diagnostic tardif. La HAS et les sociétés savantes (SFD) recommandent une amélioration du dépistage…”
Get full text

Tolérance des anti-PD1 après traitement par ipilimumab : étude observationnelle sur 29 patients by Amode, R., Baroudjian, B., Jebali, M., Chami, I., Basset-Seguin, N., Viguier, M., Comte, C., Madjlessi, N., Baccard, M., Bézier, M., Archimbaud, A., Bagot, M., Lebbé, C., Pagès, C.

“…Après l’ipilimumab (IPI), les anti-PD1 [pembrolizumab (PEM), nivolumab (NIV)] présentent, dans le traitement du mélanome métastatique, des taux de réponse, un…”
Get full text

Réintroduction d’un inhibiteur de BRAF après traitement systémique chez des patients avec mélanome métastatique by Roux, J., Pages, C., Malouf, D., Nika, M., Baccard, M., Comte, C., Archimbaud, A., Battistella, M., Viguier, M., Mourah, S., Bagot, M., Lebbé, C.

“…Les inhibiteurs de BRAF (BRAFi) ont montré une augmentation de la survie globale chez les patients (pts) atteints de mélanome (MM) métastatique muté BRAF…”
Get full text

Association Between Endothelin Receptor B Nonsynonymous Variants and Melanoma Risk by Soufir, Nadem, Meziani, Roubila, Lacapère, Jean-Jacques, Bertrand, Guylene, Fumeron, Frederic, Bourillon, Agnes, Gérard, Bénédicte, Descamps, Vincent, Crickx, Béatrice, Ollivaud, Laurence, Archimbaud, Alain, Lebbe, Céleste, Basset-Seguin, Nicole, Saiag, Philippe, Grandchamp, Bernard

“…The endothelin signaling pathway plays a crucial role in melanocyte differentiation and migration. In this study, we investigated whether germline mutations of…”
Get full text

Hypersensitivity to dacarbazine in patients with metastatic malignant melanoma by Levy, A, Guitera, P, Kerob, D, Ollivaud, L, Archimbaud, A, Dubertret, L, Basset-Seguin, N

“…Dacarbazine (DTIC) is the first-line chemotherapy for metastatic malignant melanoma without cerebral metastasis. Its clinical and hematological safety is…”
Get full text

Validation de la biopsie écho-guidée dans le diagnostic de métastase ganglionnaire de mélanome by Bohelay, G., Pagès, C., Battistella, M., Moura, S., Kerob, D., Viguier, M., Basset-Seguin, N., Madjlessi, N., Archimbaud, A., Comte, C., Bagot, M., De Kerviller, E., Lebbé, C.

Get full text

Melapred : premier test de susceptibilité au mélanome sporadique en pratique dermatologique quotidienne by Soufir, N., Gazal, S., Descamps, V., Benfodda, M., Hu, H.-H., Madjlessi, N., Lebbé, C., Basset-Seguin, N., Archimbaud, A., Becquart, J., Baccard, M., Opletalova, K., Vuong, V., Grange, A., Nicaise-Bergère, C., Renard, F., Massart-Manile, S., Bruno, M., Saiag, P., Dupin, N., Wolkenstein, P., Levy-Silbon, C., Lami, M.-C., Arnoult-Coudoux, E., Jegou, J., Colomb, M., Bagot, M., Bensussan, A., Lavolle, B., Nagore, E., Kumar, R., Grange, F.

“…Le mélanome a un pronostic redoutable en cas de diagnostic tardif, d’ou le rôle capital du dépistage précoce et de la prévention. Nous avons mis au point un…”
Get full text

Vemurafenib dans le mélanome métastatique muté BRAF : analyse d’efficacité et de tolérance chez 46 patients by Fennira, F., Pagès, C., Schneider, P., Sidina, I., Viguier, M., Basset-seguin, N., Madjelessi, N., Comte, C., Archimbaud, A., Kerob, D., Madelaine, I., Bagot, M., Battistella, M., Mourah, S., Porcher, R., Lebbé, C.

Get full text

Toxicité cutanée et inhibiteurs de BRAF by Pages, C., Viguier, M., Comte, C., Baccard, M., Archimbaud, A., Madjlessi, N., Kerob, D., Madelaine, I., Mourah, S., Bagot, M., Lebbe, C.

Get full text

Dubreuilh melanoma(lentigo maligna melanoma) by Ollivaud, L, Basset-Seguin, N, Archimbaud, A

Get more information

Pretibial epidermolysis bullosa. A rare form of epidermolysis bullosa simplex by Tsianakas, P, Fraitag, S, Archimbaud, A, Verola, O, Paul, C, Prost, C

“…Pretibial epidermolysis bullosa had been classified as a rare localized form of autosomal dominant dystrophic epidermolysis bullosa. We report a sporadic case…”
Get more information

C93 - Des variations alléliques du gène de l’endothéline 1 sont associées au risque de mélanome by Soufir, N., Meziani, R.R., Bourillon, A., Jannot, A., Gerard, B., Descamps, V., Crickx, B., Ollivaud, L., Archimbaud, A., Dupin, N., Wolkenstein, P., Vitoux, D., Lebbe, C., Basset-Seguin, N., SAIAG, P., Clerget-Darpoux, F., Grandchamp, B., Melancohort

Get full text

Double-blind study versus excipient of 0.75% metronidazole gel in the treatment of rosacea by Espagne, E, Guillaume, J C, Archimbaud, A, Baspeyras, M, Boitier, F, Bussière, M, Chamberlin, J, Coin, A, Di Crescenzo, M C, Dolivo, M

“…The proven value of tetracyclines and metronidazole administered orally in the treatment of the chronic and recurrent disease that is rosacea is tempered by…”
Get more information

A double-blind placebo-controlled study of a 2 percent foaming lotion of ketoconazole in a single application in the treatment of pityriasis versicolor by Rekacewicz, I, Guillaume, J C, Benkhraba, F, Archimbaud, A, Baspeyras, M, Boitier, F, Bussière, M, Coin, A, Di Crezenzo, M C, Duval, J

“…A double-blind, placebo-controlled therapeutic trial of ketoconazole presented as a foam and applied only once was carried out on 61 patients by a group of 15…”
Get more information